Javascript must be enabled to continue!
SEIR Transmission dynamics model of 2019 nCoV coronavirus with considering the weak infectious ability and changes in latency duration
View through CrossRef
ABSTRACT
Pneumonia patients of 2019-ncov in latent period are not easy to be effectively quarantined, but there is evidence that they have strong infectious ability. Here, the infectious ability of patients during the latent period is slightly less than that of the infected patients was assumed. We established a new SEIR propagation dynamics model, that considered the weak transmission ability of the incubation period, the variation of the incubation period length, and the government intervention measures to track and isolate comprehensively. Based on the raw epidemic data of China from January 23, 2020 to February 10, 2020, the dynamic parameters of the new present SEIR model are fitted. Through the Euler integration algorithm to solve the model, the effect of infectious ability of incubation patients on the theoretical estimation of the present SEIR model was analyzed, and the occurrence time of peak number in China was predicted.
Title: SEIR Transmission dynamics model of 2019 nCoV coronavirus with considering the weak infectious ability and changes in latency duration
Description:
ABSTRACT
Pneumonia patients of 2019-ncov in latent period are not easy to be effectively quarantined, but there is evidence that they have strong infectious ability.
Here, the infectious ability of patients during the latent period is slightly less than that of the infected patients was assumed.
We established a new SEIR propagation dynamics model, that considered the weak transmission ability of the incubation period, the variation of the incubation period length, and the government intervention measures to track and isolate comprehensively.
Based on the raw epidemic data of China from January 23, 2020 to February 10, 2020, the dynamic parameters of the new present SEIR model are fitted.
Through the Euler integration algorithm to solve the model, the effect of infectious ability of incubation patients on the theoretical estimation of the present SEIR model was analyzed, and the occurrence time of peak number in China was predicted.
Related Results
Analytical solution of l-i SEIR model–Comparison of l-i SEIR model with conventional SEIR model in simulation of epidemic curves
Analytical solution of l-i SEIR model–Comparison of l-i SEIR model with conventional SEIR model in simulation of epidemic curves
The Susceptible-Exposed-Infectious-Recovered (SEIR) epidemic model has been commonly used to analyze the spread of infectious diseases. This 4-compartment (S, E, I and R) model use...
In silico elucidation revealed SARS CoV and MERS CoV Drug Compounds could be Potential Therapeutic Candidates against Post Fusion Core (S2) Protein of Novel Coronavirus (2019-nCov)
In silico elucidation revealed SARS CoV and MERS CoV Drug Compounds could be Potential Therapeutic Candidates against Post Fusion Core (S2) Protein of Novel Coronavirus (2019-nCov)
Abstract
Novel coronavirus (2019-nCoV), since its emergence from Wuhan China in December 31, 2019 is still uncontrolled and has raised attention around the globe. According...
Analytical Solution of a New
SEIR
Model Based on Latent Period-Infectious Period Chronological Order
Analytical Solution of a New
SEIR
Model Based on Latent Period-Infectious Period Chronological Order
ABSTRACT
The Susceptible-Infectious-Recovered (
SIR
) and
SIR
derived epi...
In-silico Immunomodelling of 2019-nCoV
In-silico Immunomodelling of 2019-nCoV
Abstract
Background: Novel Corona Virus 2019 (2019-nCoV) is a positive-sense single-strand RNA virus form coronaviridae family, responsible for corona virus infectious dise...
Safety and Immunogenicity of a Booster SARS-Cov-2 Vaccination in Patients with Chronic Liver Disease
Safety and Immunogenicity of a Booster SARS-Cov-2 Vaccination in Patients with Chronic Liver Disease
ABSTRACT
This article is aim to investigate the safety and immunogenicity of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine booster in pat...
The Potential of Medicinal Plants and Bioactive Compounds in the Fight Against COVID-19
The Potential of Medicinal Plants and Bioactive Compounds in the Fight Against COVID-19
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus , is causing a serious worldwide COVID-19 pandemic. The emergence of strains with rapid spread and...
What's the Delay? Understanding Latency Across the Network
What's the Delay? Understanding Latency Across the Network
Network latency directly affects the performance of many applications that run over the Internet. While significant effort is spent on reducing network latency, the fundamental cap...
In silico identification of vaccine targets for 2019-nCoV
In silico identification of vaccine targets for 2019-nCoV
Background:
The newly identified coronavirus known as 2019-nCoV has posed a serious global health threat. According to the latest report (18-February-2020), it ...

